Inhibiting Housekeeping Enzyme Wakes P53, in Cancer Cells Only
Researchers from the Australian Peter MacCallum Cancer Centre and colleagues, including some from Cylene Pharmaceuticals Inc., have reported that by inhibiting RNA Polymerase I with their preclinical compound CX-5461, they were able to activate p53 specifically in cancer cells – a feat that researchers have been trying to achieve "for many years," Cylene CEO William Rice told BioWorld Today.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter